For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $1.28 in the prior trading day, Regulus Therapeutics Inc (NASDAQ: RGLS) closed at $1.24, down -3.12%. In other words, the price has decreased by -$3.12 from its previous closing price. On the day, 0.33 million shares were traded. RGLS stock price reached its highest trading level at $1.31 during the session, while it also had its lowest trading level at $1.24.
Ratios:
Our goal is to gain a better understanding of RGLS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.65 and its Current Ratio is at 13.65. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on August 02, 2024, initiated with a Outperform rating and assigned the stock a target price of $7.
On March 18, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $6.
On March 28, 2018, B. Riley FBR Inc. started tracking the stock assigning a Neutral rating and target price of $1.B. Riley FBR Inc. initiated its Neutral rating on March 28, 2018, with a $1 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 13 ’25 when Aker Christopher Ray sold 38,547 shares for $1.26 per share. The transaction valued at 48,693 led to the insider holds 54,634 shares of the business.
Aker Christopher Ray sold 5,088 shares of RGLS for $6,427 on Jan 14 ’25. The Sr. VP & General Counsel now owns 49,546 shares after completing the transaction at $1.26 per share. On Jan 13 ’25, another insider, Hagan Joseph P, who serves as the Chief Executive Officer of the company, sold 115,290 shares for $1.26 each. As a result, the insider received 145,634 and left with 222,572 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGLS now has a Market Capitalization of 81220128 and an Enterprise Value of -4843834.
Stock Price History:
The Beta on a monthly basis for RGLS is 1.62, which has changed by 0.059829116 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, RGLS has reached a high of $3.79, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is -17.85%, while the 200-Day Moving Average is calculated to be -31.17%.
Shares Statistics:
The stock has traded on average 357.26K shares per day over the past 3-months and 377720 shares per day over the last 10 days, according to various share statistics. A total of 65.50M shares are outstanding, with a floating share count of 52.66M. Insiders hold about 19.98% of the company’s shares, while institutions hold 69.97% stake in the company. Shares short for RGLS as of 1735603200 were 1695685 with a Short Ratio of 4.75, compared to 1732838400 on 1401340. Therefore, it implies a Short% of Shares Outstanding of 1695685 and a Short% of Float of 3.2899998.
